Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris-Stephan Rauchmann

Showing results (1-10 of 108) with videos related to

Pageof 11
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2024
Analysis of Resting-State Functional Magnetic Resonance Imaging in Alzheimer's DiseaseErsin Ersözlü, Boris-Stephan Rauchmann
Journal of Alzheimer'S Disease : JAD|January 21, 2020
Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal FluidBoris-Stephan Rauchmann, Angélique Sadlon, Robert Perneczky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 30, 2021
Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognitionBoris Stephan Rauchmann, Thomas Schneider-Axmann, Robert Perneczky, et al.
Radiology|May 6, 2020
Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET ImagingBoris-Stephan Rauchmann, Farhad Ghaseminejad, Shailaja Mekala, et al.
Neuropathology and Applied Neurobiology|November 25, 2021
Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studiesCarolin Kurz, Lauren Walker, Boris-Stephan Rauchmann, et al.
Neurobiology of Aging|November 21, 2018
CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuumBoris-Stephan Rauchmann, Thomas Schneider-Axmann, Panagiotis Alexopoulos, et al.
Aging Clinical and Experimental Research|June 25, 2026
Head-to-head comparison of neurodegeneration biomarkers across two analytical platforms in Alzheimer's diseaseCarolin Kurz, Daniela Hattenkofer, Maximilian Pihale-Haug, et al.
Brain Imaging and Behavior|January 17, 2017
White matter alterations in college football players: a longitudinal diffusion tensor imaging studyMichael Christian Mayinger, Kian Merchant-Borna, Jakob Hufschmidt, et al.
Alzheimer'S Research & Therapy|June 13, 2026
Estimation of positron emission tomography amyloid load and related biomarkers in Alzheimer's disease using evoked potential tomography EEG: development and internal validation in a cross-sectional cohortBoris-Stephan Rauchmann, James Hamet, Jesyin Lai, et al.
Diagnostics (Basel, Switzerland)|July 29, 2025
Diagnostics and Group Therapy in Patients with Persistent Postural-Perceptual Dizziness and Anxiety Disorder: Biomarkers and Neurofunctional Correlates of Underlying Treatment EffectsMaximilian Maywald, Oliver Pogarell, Agnieszka Chrobok, et al.
Pageof 11

Showing results (1-10 of 108) with videos related to

Sort By:
Pageof 11
Methods in Molecular Biology (Clifton, N.J.)|March 1, 2024
Analysis of Resting-State Functional Magnetic Resonance Imaging in Alzheimer's DiseaseErsin Ersözlü, Boris-Stephan Rauchmann
Journal of Alzheimer'S Disease : JAD|January 21, 2020
Soluble TREM2 and Inflammatory Proteins in Alzheimer's Disease Cerebrospinal FluidBoris-Stephan Rauchmann, Angélique Sadlon, Robert Perneczky, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 30, 2021
Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognitionBoris Stephan Rauchmann, Thomas Schneider-Axmann, Robert Perneczky, et al.
Radiology|May 6, 2020
Cerebral Microhemorrhage at MRI in Mild Cognitive Impairment and Early Alzheimer Disease: Association with Tau and Amyloid β at PET ImagingBoris-Stephan Rauchmann, Farhad Ghaseminejad, Shailaja Mekala, et al.
Neuropathology and Applied Neurobiology|November 25, 2021
Dysfunction of the blood-brain barrier in Alzheimer's disease: Evidence from human studiesCarolin Kurz, Lauren Walker, Boris-Stephan Rauchmann, et al.
Neurobiology of Aging|November 21, 2018
CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuumBoris-Stephan Rauchmann, Thomas Schneider-Axmann, Panagiotis Alexopoulos, et al.
Aging Clinical and Experimental Research|June 25, 2026
Head-to-head comparison of neurodegeneration biomarkers across two analytical platforms in Alzheimer's diseaseCarolin Kurz, Daniela Hattenkofer, Maximilian Pihale-Haug, et al.
Brain Imaging and Behavior|January 17, 2017
White matter alterations in college football players: a longitudinal diffusion tensor imaging studyMichael Christian Mayinger, Kian Merchant-Borna, Jakob Hufschmidt, et al.
Alzheimer'S Research & Therapy|June 13, 2026
Estimation of positron emission tomography amyloid load and related biomarkers in Alzheimer's disease using evoked potential tomography EEG: development and internal validation in a cross-sectional cohortBoris-Stephan Rauchmann, James Hamet, Jesyin Lai, et al.
Diagnostics (Basel, Switzerland)|July 29, 2025
Diagnostics and Group Therapy in Patients with Persistent Postural-Perceptual Dizziness and Anxiety Disorder: Biomarkers and Neurofunctional Correlates of Underlying Treatment EffectsMaximilian Maywald, Oliver Pogarell, Agnieszka Chrobok, et al.
Pageof 11